Delivering biologics via oral administration represents a growing market that is expected to exhibit 35% CAGR from 2023–2028.

Prostate cancer and other cancers characterized by “cold” tumors could become more responsive to checkpoint blockade if UBA1 is inhibited.

Enveda’s pipeline is led by ENV-294, a first-in-class, oral small molecule being developed to treat atopic dermatitis and other inflammatory conditions by combining the advantages of blockbuster drugs ...

Kraig Biocraft Laboratories has developed transgenic silkworms to produce spider silk in commercial quantities.

At GEN’s inaugural virtual summit on The State of AI in Drug Discovery, experts evaluated the evolution, opportunities, and ...

Thaysen stepped in to lead Illumina through a tumultuous time, and now—as this GEN interview relates—he is carrying out his near- and long-term plans for the company.

Biomanufacturers can avoid downstream detours if they are guided less by trial and error, and more by machine learning.

Knowledge extraction: Through the application of AI and knowledge graphs, Wisecube were able to explore repurposed drugs for ...

SmartLabs’ new Custom Developed Solutions (CDS) platform provides specialized oversight and hands-on expertise in the design, ...